Sangamo Therapeutics(SGMO)

泼天财富我自来07-26 10:27

$Sangamo Therapeutics(SGMO)$ 补充更新一下
2024/7/24 该公司公布和辉瑞合作开发血友病基因药物三期达标，股价暴涨，后续可期！查看全文

产业链观察07-24 21:24

#药闻简讯# 2024 年 7 月 24 日，$辉瑞(PFE)$ 今天宣布了评估giroctocogene fitelparvovec的3期研究（NCT04370054）的积极顶线结果，该研究是一种用于治疗中度至重度血友病A成人的研究性基因疗法。$Sangamo Therapeutics(SGMO)$查看全文

当期报告

Sangamo Therapeutics(SGMO)2023-11-04 04:05

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-23-036697  Act: 34  Size: 1 MB 网页链接查看全文

员工持股计划

Sangamo Therapeutics(SGMO)2023-08-09 04:55

$Sangamo Therapeutics(SGMO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-206301  Act: 33  Size: 73 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047586  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047590  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001756  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001754  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001755  Size: 6 KB 网页链接查看全文

其他

Sangamo Therapeutics(SGMO)04-20 04:25

$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893  Act: 34  Size: 17 MB 网页链接查看全文

酱油小朋友2015-02-20 04:35

$Sangamo Biosciences (SGMO)$ 查看全文

haulk2015-02-19 23:07

$Sangamo Biosciences (SGMO)$ 管理层狂抛是几个意思？查看全文

酱油小朋友2015-02-19 02:05

$Sunesis Pharmaceuticals(SNSS)$ 走起 $Sangamo Biosciences (SGMO)$ 走着查看全文

hmmmmmmm62015-02-19 01:03

$Bellicum Pharmaceuticals (BLCM)$ 开关技术绝逼是CAR-T平台中的王者，真应该跟$Sangamo Biosciences (SGMO)$ 的ZFP基因修饰平台双剑合璧；CAR-T大家只知道juno，gene-therapy大家只知道blue，其实真黑科技的是另外两家，坐等clinical results justify查看全文

超级大坏蛋12015-02-19 00:02

$Sangamo Biosciences (SGMO)$ 突破，加仓！[成交]查看全文

hmmmmmmm62015-02-15 18:27

$Sangamo Biosciences (SGMO)$ 仔细听了几大conference pre，SGMO的ZFP技术平台达到Bluebird的治疗效果只是时间的问题，毕竟hemo program13年末才开始；SGMO的therapy较bluebird和其它平台更精确，是DNA层面外科手术式的操作，如果效果和其它平台相同，仍将因为精确性成为首选，毕竟其它平台在人体...查看全文

疑夕2015-02-13 20:20

$疑夕医药(ZH191759)$ $XenoPort(XNPT)$ 从走势上来看要反攻，价格也不算贵，加仓4%试试；$Sangamo Biosciences (SGMO)$ 连续两天大涨，作为艾滋病第一股，长期风险倒也不大，而且目前6000-7000万的营收能一定程度上填补研发费用。查看全文

王伟CFA美股MCORLEO2015-02-13 03:29

$Sangamo Biosciences (SGMO)$ 感谢老白 我快解套了 还差4毛 @股市之猪老白ISIG查看全文

华1002015-02-11 11:54

$Sangamo Biosciences (SGMO)$15.8成本在耐心的等查看全文

幻想交响曲2015-02-11 05:10

$Sangamo Biosciences (SGMO)$ 第一次拿着过财报，给我赚点吧！[跪了]查看全文

上行空间均超50%，RBC力荐这三只潜力股

智通财经APP获悉，近期，RBC针对Verrica Pharmaceuticals(VRCA.US)、Sangamo Therapeutics(SGMO.US)、GooseHead Insurance(GSHD.US)三家公司发表研报，并强调了这三只股票未来强劲的长期增长前景，预计在未来一年的上行空间将至少达到50... 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-24-032815  Act: 34  Size: 287 KB 网页链接

超过5%股东持股披露「修订」

$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008122  Act: 34  Size: 12 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016686  Size: 6 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015752  Size: 8 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015753  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015754  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015755  Size: 8 KB 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-026903  Act: 34  Size: 13 MB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014796  Size: 9 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014798  Size: 9 KB 网页链接